Fresh Equities



Company Information

Acrux Limited (ACR) is an Australian drug delivery company, who is developing and commercialising pharmaceutical products for global markets. ACR uses innovative technology to administer medicines through the skin. ACR conducts its operations in Australia, Switzerland, USA and overseas, with three marketed products including AXIRON, Evamist and Recuvyra. Former Names --


Listed Company

GICS Sub-Industry


Head Office

103-113 Stanley St, West Melbourne VIC 3003, Australia

Health Care

Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.

Fresh Equities

Copyright © 2018 Fresh Equities. All rights reserved.

ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by Fresh Equities Pty Ltd, its representatives or any other third party regardless of whether such security, product or service is referenced on this website.